UK - Apax to acquire Marken in £975m deal
Apax Partners has agreed to aquire Marken, a specialist in clinical drug trial logistics, from management and mezzanine lender ICG in a deal reportedly valued at ТЃ975m.
The deal, which is expected to complete in early 2010, will become the largest private equity deal in the UK for more than a year. Management, led by chief executive Bruce Craig, is expected to roll over a large share of the proceeds from the transaction to retain a significant minority stake in the company alongside Apax, who will hold approximately two thirds of the business.
The sale is expected to return proceeds of £170m to ICG, of which £68m is profit.
Apax is thought to be underwriting the entire acquisition cost, but is currently in discussions with banks over raising some debt to finance the transaction before it closes.
Brentford-based Marken is a specialised logistics and support services company for the biopharmaceutical industry. Its services include export of trial medication, vaccines and clinical trial material, protocol support and regulatory advice. The company was founded in 1980.
It has been reported that Apax beat off competition from rival private equity firms including Hellman & Friedman for the acquisition.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








